Factors Affecting Dissolution Rate of Sulpiride from Tablets Coated with Polyvinylacetal Diethylaminoacetate, a Gastric-Fluid-Soluble Polymer. I. Effect of Ionic Strength of Gastrointestinal Fluids

The bioavailability of sulpiride (SP) from a tablet coated with AEA [○!R] (polyvinylacetal diethylaminoacetate), used as a gastric-fluid-soluble polymer, is very poor in low gastric acidity subjects in the fasting state but improves after food intake. To analyze the factors affecting SP bioavailabil...

Full description

Saved in:
Bibliographic Details
Published inChemical & pharmaceutical bulletin Vol. 43; no. 7; pp. 1204 - 1211
Main Authors YAMANAKA, You, MIZUNO, Nobuyasu, TAMURA, Shigeki, HAMAGUCHI, Tsuneo, MIYAKE, Masatoshi, SHINKUMA, Denji
Format Journal Article
LanguageEnglish
Published Tokyo The Pharmaceutical Society of Japan 15.07.1995
公益社団法人日本薬学会
Maruzen
Japan Science and Technology Agency
Subjects
Online AccessGet full text
ISSN0009-2363
1347-5223
DOI10.1248/cpb.43.1204

Cover

Abstract The bioavailability of sulpiride (SP) from a tablet coated with AEA [○!R] (polyvinylacetal diethylaminoacetate), used as a gastric-fluid-soluble polymer, is very poor in low gastric acidity subjects in the fasting state but improves after food intake. To analyze the factors affecting SP bioavailability from an AEA [○!R] film-coated tablet (AEA [○!R] tablet), we prepared AEA [○!R] cast film and AEA [○!R] tablets and investigated the physicochemical properties of gastrointestinal (GI) fluids affecting the dissolution of the film coating and the dissolution rate of SP from the tablets. The dissolution time of AEA [○!R] cast film was shortened with an increase in the ionic strength of the medium, but was delayed by an increase in viscosity and addition of sodium taurocholate to the medium. The AEA [○!R] tablet showed rapid dissolution of SP at pH 4 or below but not when the pH was 5.0 or above. In pH 5.0-5.8 media, the SP dissolution rate from the tablet increased as the ionic strength (μ) of the medium rose, reaching maximum at μ=0.3. Microscopic observations and measurements of film coating thickness revealed that the increased dissolution rate of SP from the tablet with higher ionic strength (μ=0.3) was due to promotion of the dissolution of the AEA [○!R] film coating. Data from pH titration showed that increased ionic strength (μ=0.3) resulted in higher apparent dissociation, which increased the solubility of AEA [○!R] in the medium. We concluded that the ionic strength in GI fluids is one of the factors affecting the bioavailability from AEA [○!R] tablet. After food intake, the bioavailability of SP from the tablet improves, probably due to increased apparent dissociation of AEA [○!R] caused by an increase in ionic strength from the meal (ca. μ=0.3). This increases the dissolution rate of the film coating and thus, the dissolution rate of SP from the AEA [○!R] tablet, leading to enhanced absorption.
AbstractList The bioavailability of sulpiride (SP) from a tablet coated with AEA [○!R] (polyvinylacetal diethylaminoacetate), used as a gastric-fluid-soluble polymer, is very poor in low gastric acidity subjects in the fasting state but improves after food intake. To analyze the factors affecting SP bioavailability from an AEA [○!R] film-coated tablet (AEA [○!R] tablet), we prepared AEA [○!R] cast film and AEA [○!R] tablets and investigated the physicochemical properties of gastrointestinal (GI) fluids affecting the dissolution of the film coating and the dissolution rate of SP from the tablets. The dissolution time of AEA [○!R] cast film was shortened with an increase in the ionic strength of the medium, but was delayed by an increase in viscosity and addition of sodium taurocholate to the medium. The AEA [○!R] tablet showed rapid dissolution of SP at pH 4 or below but not when the pH was 5.0 or above. In pH 5.0-5.8 media, the SP dissolution rate from the tablet increased as the ionic strength (μ) of the medium rose, reaching maximum at μ=0.3. Microscopic observations and measurements of film coating thickness revealed that the increased dissolution rate of SP from the tablet with higher ionic strength (μ=0.3) was due to promotion of the dissolution of the AEA [○!R] film coating. Data from pH titration showed that increased ionic strength (μ=0.3) resulted in higher apparent dissociation, which increased the solubility of AEA [○!R] in the medium. We concluded that the ionic strength in GI fluids is one of the factors affecting the bioavailability from AEA [○!R] tablet. After food intake, the bioavailability of SP from the tablet improves, probably due to increased apparent dissociation of AEA [○!R] caused by an increase in ionic strength from the meal (ca. μ=0.3). This increases the dissolution rate of the film coating and thus, the dissolution rate of SP from the AEA [○!R] tablet, leading to enhanced absorption.
The bioavailability of sulpiride (SP) from a tablet coated with AEA [[white circle]!R] (polyvinylacetal diethylaminoacetate), used as a gastric-fluid-soluble polymer, is very poor in low gastric acidity subjects in the fasting state but improves after food intake. To analyze the factors affecting SP bioavailability from an AEA [[white circle]!R] film-coated tablet (AEA [[white circle]!R] tablet), we prepared AEA [[white circle]!R] cast film and AEA [[white circle]!R] tablets and investigated the physicochemical properties of gastrointestinal (GI) fluids affecting the dissolution of the film coating and the dissolution rate of SP from the tablets. The dissolution time of AEA [[white circle]!R] cast film was shortened with an increase in the ionic strength of the medium, but was delayed by an increase in viscosity and addition of sodium taurocholate to the medium. The AEA [[white circle]!R] tablet showed rapid dissolution of SP at pH 4 or below but not when the pH was 5.0 or above. In pH 5.0-5.8 media, the SP dissolution rate from the tablet increased as the ionic strength (μ) of the medium rose, reaching maximum at μ=0.3. Microscopic observations and measurements of film coating thickness revealed that the increased dissolution rate of SP from the tablet with higher ionic strength (μ=0.3) was due to promotion of the dissolution of the AEA [[white circle]!R] film coating. Data from pH titration showed that increased ionic strength (μ=0.3) resulted in higher apparent dissociation, which increased the solubility of AEA [[white circle]!R] in the medium. We concluded that the ionic strength in GI fluids is one of the factors affecting the bioavailability from AEA [[white circle]!R] tablet. After food intake, the bioavailability of SP from the tablet improves, probably due to increased apparent dissociation of AEA [[white circle]!R] caused by an increase in ionic strength from the meal (ca. μ=0.3). This increases the dissolution rate of the film coating and thus, the dissolution rate of SP from the AEA [[white circle]!R] tablet, leading to enhanced absorption.
Author TAMURA, Shigeki
SHINKUMA, Denji
HAMAGUCHI, Tsuneo
MIZUNO, Nobuyasu
YAMANAKA, You
MIYAKE, Masatoshi
Author_FL SHINKUMA Denji
MIYAKE Masatoshi
HAMAGUCHI Tsuneo
MIZUNO Nobuyasu
TAMURA Shigeki
YAMANAKA You
Author_FL_xml – sequence: 1
  fullname: HAMAGUCHI Tsuneo
– sequence: 2
  fullname: SHINKUMA Denji
– sequence: 3
  fullname: YAMANAKA You
– sequence: 4
  fullname: MIYAKE Masatoshi
– sequence: 5
  fullname: TAMURA Shigeki
– sequence: 6
  fullname: MIZUNO Nobuyasu
Author_xml – sequence: 1
  fullname: YAMANAKA, You
– sequence: 1
  fullname: MIZUNO, Nobuyasu
– sequence: 1
  fullname: TAMURA, Shigeki
– sequence: 1
  fullname: HAMAGUCHI, Tsuneo
– sequence: 1
  fullname: MIYAKE, Masatoshi
– sequence: 1
  fullname: SHINKUMA, Denji
BackLink https://cir.nii.ac.jp/crid/1570009752440589824$$DView record in CiNii
http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=3645777$$DView record in Pascal Francis
BookMark eNpFUV1vEzEQtFCRSAtP_AFL8MgFf57vHqu0KZEqgUh5Pjm-vcSRYwfbV5QfyP_CuVT0Ze3dnZ0Zaa7RlQ8eEPpIyZwy0Xw1x81c8PIn4g2aUS5UJRnjV2hGCGkrxmv-Dl2ntCeESaL4DP1dapNDTPh2GMBk67f4zqYU3Jht8PinzoDDgNejO9poe8BDDAf8pDcOcsKLUPY9_mPzDv8I7vRs_clpA1m7QgN5V7qD9WEaZfiCNX7QKUdrqqUbbV-ti1Chmo4PEOd4Ncf3k5Oz6ip4a_A6R_DbolAm03WwPkMqXovKRJPeo7eDdgk-vLw36Nfy_mnxrXr8_rBa3D5We0ZlrpQW3Mh-IIYKXdcwtC2Vimm2YUZT1tON4r1qgQlGG2XMwDlAzySDXtUDB36DPl14jzH8HouHbh_GWHykjoqasFooWRfU5xeUTka7IWpvbOqO0R50PHW8FlIp9Qrz1nbGnmtxcw5KSSYEkU3bMFFgdxfYPmW9hf80OmZrHHQlc9rKphO8U5dyjv91vdOxA8__AQVOrCE
CODEN CPBTAL
ContentType Journal Article
Copyright The Pharmaceutical Society of Japan
1995 INIST-CNRS
Copyright Japan Science and Technology Agency 1995
Copyright_xml – notice: The Pharmaceutical Society of Japan
– notice: 1995 INIST-CNRS
– notice: Copyright Japan Science and Technology Agency 1995
DBID RYH
IQODW
7TK
7TM
7U9
H94
K9.
DOI 10.1248/cpb.43.1204
DatabaseName CiNii Complete
Pascal-Francis
Neurosciences Abstracts
Nucleic Acids Abstracts
Virology and AIDS Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
DatabaseTitle AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Virology and AIDS Abstracts
Neurosciences Abstracts
Nucleic Acids Abstracts
DatabaseTitleList

AIDS and Cancer Research Abstracts
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1347-5223
EndPage 1211
ExternalDocumentID 3133001651
3645777
110003631635
article_cpb1958_43_7_43_7_1204_article_char_en
GroupedDBID ---
.55
2WC
53G
5GY
6J9
ACGFO
ACIWK
ACPRK
ADBBV
AENEX
AFRAH
AI.
ALMA_UNASSIGNED_HOLDINGS
BAWUL
CS3
DIK
DU5
EBS
EJD
F5P
GX1
HH5
JSF
JSH
KQ8
L7B
OK1
P2P
RJT
RZJ
TKC
TR2
VH1
X7M
ZGI
ZY4
RYH
.GJ
29B
3O-
BKOMP
E3Z
IQODW
JMI
MOJWN
X7J
XSB
ZE2
7TK
7TM
7U9
H94
K9.
ID FETCH-LOGICAL-j215t-7a43c5df0c14a66ef991572a2b2ca12d1b73d79e242187ccf33eed252ed76f3e3
ISSN 0009-2363
IngestDate Sat Sep 20 14:11:57 EDT 2025
Mon Jul 21 09:16:19 EDT 2025
Thu Jun 26 22:54:31 EDT 2025
Wed Sep 03 06:26:30 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 7
Keywords Phosphates
Stomach
Pharmaceutical technology
Control release polymer
Psychotropic
Bile salt
Acetate
Bioavailability
Buffer solution
Dissolution
In vitro
Vinyl acetate polymer
Medium effect
Ionic strength
Antisecretory agent
Dosage form
pH
Active ingredient
Kinetics
Aqueous solution
Coated tablet
Release
Physicochemical properties
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-j215t-7a43c5df0c14a66ef991572a2b2ca12d1b73d79e242187ccf33eed252ed76f3e3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
OpenAccessLink https://www.jstage.jst.go.jp/article/cpb1958/43/7/43_7_1204/_article/-char/en
PQID 1460264756
PQPubID 1996362
PageCount 8
ParticipantIDs proquest_journals_1460264756
pascalfrancis_primary_3645777
nii_cinii_1570009752440589824
jstage_primary_article_cpb1958_43_7_43_7_1204_article_char_en
PublicationCentury 1900
PublicationDate 1995-07-15
PublicationDateYYYYMMDD 1995-07-15
PublicationDate_xml – month: 07
  year: 1995
  text: 1995-07-15
  day: 15
PublicationDecade 1990
PublicationPlace Tokyo
PublicationPlace_xml – name: Tokyo
PublicationTitle Chemical & pharmaceutical bulletin
PublicationTitleAlternate Chem. Pharm. Bull.
PublicationTitle_FL Chem. Pharm. Bull
PublicationYear 1995
Publisher The Pharmaceutical Society of Japan
公益社団法人日本薬学会
Maruzen
Japan Science and Technology Agency
Publisher_xml – name: The Pharmaceutical Society of Japan
– name: 公益社団法人日本薬学会
– name: Maruzen
– name: Japan Science and Technology Agency
References 12) "Catalog of HPMCP," Shinetsu Chemical Co., Ltd., Tokyo, 1991, p. 2.
6) Shinkuma D., Hamaguchi T., Kobayashi M., Yamanaka Y., Mizuno N., Int. J. Clin. Pharmacol. Ther. Toxicol., 29, 303 (1991).
14) Ogata H., Shibazaki T., Inoue T., Ejima A., J. Pharm. Sci., 68, 708 (1979).
8) Hayashi M., Nagai T., Nogami H., Chem. Pharm. Bull., 18, 2350 (1970).
10) Mizuno N., Shimizu C., Morita E., Shinkuma D., Yamanaka Y., Yakuzaigaku, 43, 209 (1983).
11) Tomida Y., Yokohama S., Maki M., Toguchi H., Shimamoto T., J. Takeda Res. Lab., 36, 83 (1977).
9) Sjoqvist R., Nyqvist H., Sjovall J., Westerlund D., J. Micro-encapsulation, 2, 123 (1985).
1) Ogata H., Aoyagi N., Kaniwa N., Shibazaki T., Ejima E., Takagishi Y., Ogura T., Tomita K., Inoue S., Zaizen M., Int. J. Pharmaceut., 23, 277 (1985).
5) Shinkuma D., Hamaguchi T., Kobayashi M., Yamanaka Y., Mizuno N., Int. J. Clin. Pharmacol. Ther. Toxicol., 28,440 (1990).
7) "Catalog of AEA, Sankyo," Sankyo K.K., Tokyo, 1987, pp. 6-7.
4) Shinkuma D., Hamaguchi T., Kobayashi M., Yamanaka Y., Mizuno N., Int. J. Clin. Pharmacol. Ther. Toxicol., 27, 499 (1989).
13) Ogata H., Shibazaki T., Inoue T., Ejima A., J. Pharm. Sci., 68, 712 (1979).
15) Armand J.Y., Magnard F., Bouzon J., Rollet J., Taverdet J.L., Vergnaud J.M., Int. J. Pharmaceut., 40, 33 (1987).
3) Shinkuma D., Hamaguchi T., Kobayashi M., Yamanaka Y., Mizuno N., Yakuzaigaku, 48, 106 (1988).
2) Aoyagi N., Ogata H., Kaniwa N., Koibuchi M., Shibazaki T., Ejima A., Mizobe M., Kohno K., Samejima M., Chem. Pharm. Bull., 34, 281 (1986).
References_xml – reference: 6) Shinkuma D., Hamaguchi T., Kobayashi M., Yamanaka Y., Mizuno N., Int. J. Clin. Pharmacol. Ther. Toxicol., 29, 303 (1991).
– reference: 1) Ogata H., Aoyagi N., Kaniwa N., Shibazaki T., Ejima E., Takagishi Y., Ogura T., Tomita K., Inoue S., Zaizen M., Int. J. Pharmaceut., 23, 277 (1985).
– reference: 15) Armand J.Y., Magnard F., Bouzon J., Rollet J., Taverdet J.L., Vergnaud J.M., Int. J. Pharmaceut., 40, 33 (1987).
– reference: 4) Shinkuma D., Hamaguchi T., Kobayashi M., Yamanaka Y., Mizuno N., Int. J. Clin. Pharmacol. Ther. Toxicol., 27, 499 (1989).
– reference: 9) Sjoqvist R., Nyqvist H., Sjovall J., Westerlund D., J. Micro-encapsulation, 2, 123 (1985).
– reference: 10) Mizuno N., Shimizu C., Morita E., Shinkuma D., Yamanaka Y., Yakuzaigaku, 43, 209 (1983).
– reference: 13) Ogata H., Shibazaki T., Inoue T., Ejima A., J. Pharm. Sci., 68, 712 (1979).
– reference: 7) "Catalog of AEA, Sankyo," Sankyo K.K., Tokyo, 1987, pp. 6-7.
– reference: 2) Aoyagi N., Ogata H., Kaniwa N., Koibuchi M., Shibazaki T., Ejima A., Mizobe M., Kohno K., Samejima M., Chem. Pharm. Bull., 34, 281 (1986).
– reference: 11) Tomida Y., Yokohama S., Maki M., Toguchi H., Shimamoto T., J. Takeda Res. Lab., 36, 83 (1977).
– reference: 12) "Catalog of HPMCP," Shinetsu Chemical Co., Ltd., Tokyo, 1991, p. 2.
– reference: 14) Ogata H., Shibazaki T., Inoue T., Ejima A., J. Pharm. Sci., 68, 708 (1979).
– reference: 3) Shinkuma D., Hamaguchi T., Kobayashi M., Yamanaka Y., Mizuno N., Yakuzaigaku, 48, 106 (1988).
– reference: 8) Hayashi M., Nagai T., Nogami H., Chem. Pharm. Bull., 18, 2350 (1970).
– reference: 5) Shinkuma D., Hamaguchi T., Kobayashi M., Yamanaka Y., Mizuno N., Int. J. Clin. Pharmacol. Ther. Toxicol., 28,440 (1990).
SSID ssj0025073
Score 1.4744102
Snippet The bioavailability of sulpiride (SP) from a tablet coated with AEA [○!R] (polyvinylacetal diethylaminoacetate), used as a gastric-fluid-soluble polymer, is...
The bioavailability of sulpiride (SP) from a tablet coated with AEA ^<[○!R]> (polyvinylacetal diethylaminoacetate), used as a gastric-fluid-soluble polymer, is...
The bioavailability of sulpiride (SP) from a tablet coated with AEA [[white circle]!R] (polyvinylacetal diethylaminoacetate), used as a gastric-fluid-soluble...
SourceID proquest
pascalfrancis
nii
jstage
SourceType Aggregation Database
Index Database
Publisher
StartPage 1204
SubjectTerms AEA [○!R]
Biological and medical sciences
dissociation
dissolution rate
film-coated tablet
General pharmacology
ionic strength
Medical sciences
Pharmaceutical technology. Pharmaceutical industry
Pharmacology. Drug treatments
sulpiride
Title Factors Affecting Dissolution Rate of Sulpiride from Tablets Coated with Polyvinylacetal Diethylaminoacetate, a Gastric-Fluid-Soluble Polymer. I. Effect of Ionic Strength of Gastrointestinal Fluids
URI https://www.jstage.jst.go.jp/article/cpb1958/43/7/43_7_1204/_article/-char/en
https://cir.nii.ac.jp/crid/1570009752440589824
https://www.proquest.com/docview/1460264756
Volume 43
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Chemical and Pharmaceutical Bulletin, 1995/07/15, Vol.43(7), pp.1204-1211
journalDatabaseRights – providerCode: PRVFSB
  databaseName: Free Full-Text Journals in Chemistry
  customDbUrl:
  eissn: 1347-5223
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0025073
  issn: 0009-2363
  databaseCode: HH5
  dateStart: 19580101
  isFulltext: true
  titleUrlDefault: http://abc-chemistry.org/
  providerName: ABC ChemistRy
– providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 1347-5223
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0025073
  issn: 0009-2363
  databaseCode: KQ8
  dateStart: 19580101
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVBFR
  databaseName: Free Medical Journals
  customDbUrl:
  eissn: 1347-5223
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0025073
  issn: 0009-2363
  databaseCode: DIK
  dateStart: 19580101
  isFulltext: true
  titleUrlDefault: http://www.freemedicaljournals.com
  providerName: Flying Publisher
– providerCode: PRVFQY
  databaseName: GFMER Free Medical Journals
  customDbUrl:
  eissn: 1347-5223
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0025073
  issn: 0009-2363
  databaseCode: GX1
  dateStart: 0
  isFulltext: true
  titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php
  providerName: Geneva Foundation for Medical Education and Research
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3Nb9MwFLfWceGC-BQdG_IB7dImNJ9uDxyqQddu2ihbK01cIidxtoyRTG2CVP4__i_es530gx4YXKzIieMk7_3sn533Qcg7bouoG2IOQBY6hgtTKBy5iYH0IEqc2A1lUJ-zc384dU-uvKudhrVitVQWoRn93OpX8i9ShTqQK3rJPkCy9U2hAo5BvlCChKH8KxkPdLKcvjTKwEX_x7TusnXBlQnAJSYYnqWxUL4kE3SWKjBVJy8q2_Nxfrf4kWYL3FMv5EAoQICgLGmWyyqVRI-3jjnm-YiMwV2ZxgbuqaHnFTb_LmZma2S2dDhk9FCRyXXwt3d2DX1AjWydY4QKGFiQBsvbzFcJ8loAg_HN2ob7WqhwHKn6mI_gtC-nkbysdWf0dXr-Wf2UCssFn9dnJv2z6YW8_PImvRbf0lqp4U7H06PhSKrvvMxEvtwOUe7lzFAOoWblULfxcJX5K7zmCRCQbG066Bm2o0dYoWYAx2WwOldO0NUUoSJJaSiwlfHeslXyZM0dMF7e1nnJdtHXIroPTdcxl43WAn1rNQrgKowAFLhOwFSBDYL6NLwdKH-DPLKZ72PSjtMv9Y8zILSsTh6Ib6ZdUqH_9yu9A926hcUHRpVoZGmKBsF8Dt8qUclc_uAlkmxNnpInepVE--phnpEdkT0nh_qLL9p0svQanLfpIR0vA7AvXpBfGhe0xgVdwQVFXNA8oTUuKOKCalxQhQuKuKAbuKBbcNGmnG5FBa1QQUcmVajAXiUqaIUKrNlEBVWoeEmmg0-To6Gh05UYt8CbC4Nx14m8OOlElst9XySw9PKYze3Qjrhlx1bInJj1BBphdFkEI6EDBNX2bBEzP3GE84rsZnkmXhPqxKACvThKLOG7sd_tAmsPOfCSrvB4wqIm-aDkF9yrmDTBw5SnSQ5A7EGUYmlhiotOj3nA9DHJaNd24fyaQtTdoNECY6xJ9isFCfR4OMdNhA4sr5jn7_3n470hj5fQ3ie7xawUB8D9i_Ct1Pbfon4Pfw
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Factors+Affecting+Dissolution+Rate+of+Sulpiride+from+Tablets+Coated+with+Polyvinylacetal+Diethylaminoacetate%2C+a+Gastric-Fluid-Soluble+Polymer.+I.+Effect+of+Ionic+Strength+of+Gastrointestinal+Fluids&rft.jtitle=Chemical+and+Pharmaceutical+Bulletin&rft.au=YAMANAKA%2C+You&rft.au=MIZUNO%2C+Nobuyasu&rft.au=TAMURA%2C+Shigeki&rft.au=HAMAGUCHI%2C+Tsuneo&rft.date=1995-07-15&rft.pub=The+Pharmaceutical+Society+of+Japan&rft.issn=0009-2363&rft.eissn=1347-5223&rft.volume=43&rft.issue=7&rft.spage=1204&rft.epage=1211&rft_id=info:doi/10.1248%2Fcpb.43.1204&rft.externalDocID=article_cpb1958_43_7_43_7_1204_article_char_en
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0009-2363&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0009-2363&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0009-2363&client=summon